PATRYS LIMITED - Announcements

Market Cap $18.51M Add to my watchlist

Healthcare Biotechnology

Patrys Limited is an Australia-based company, which is focused on the development of its... Patrys Limited is an Australia-based company, which is focused on the development of its deoxymab platform of cell-penetrating antibodies as therapies for a range of different cancers. The Company's deoxymab platform is based on the deoxymab 3E10 antibody that was identified as an autoantibody in a mouse model of the human disease systemic lupus erythematosus. It has developed two humanized forms of deoxymab 3E10, both of which have improved activity over the original deoxymab 3E10 antibody: PAT-DX1, which is a dimer (two joined subunits) of the short chain from the binding domain of deoxymab 3E10, and PAT-DX3, which is a full-sized Immunoglobulin G antibody. Deoxymabs, such as PAT-DX1 and PAT-DX3, can be used to target nanoparticles carrying a payload of anti-cancer drugs specifically to tumors. Its PAT-DX1- nanoparticles (NP) pipeline involves using its PAT-DX1 to develop a new drug based on the targeted delivery of NP carrying therapeutic payloads to the inside of cancer cells.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

PAB	Results of Meeting - 2012 AGM		31/10/12	365.59KB	Share
PAB	CEO Presentation to AGM 2012		31/10/12	1.35MB	Share
PAB	Patrys Research Recognised by Leading Oncology Society		25/10/12	277.81KB	Share
PAB	Appendix 4C - Quarterly Cash Flow - September 2012	PRICE SENSITIVE	12/10/12	66.85KB	Share
PAB	Notice of Annual General Meeting/Proxy Form		28/09/12	615.07KB	Share
PAB	New Data Published on Patrys' PAT-SM6 Lead Product	PRICE SENSITIVE	21/09/12	350.5KB	Share
PAB	Patrys Receives Approval for Multiple Myeloma Trial	PRICE SENSITIVE	20/09/12	350.29KB	Share
PAB	Change of Director's Interest Notice		10/09/12	96.06KB	Share
PAB	Change of Director's Interest Notice		10/09/12	95.98KB	Share
PAB	Change of Director's Interest Notice		10/09/12	97.41KB	Share
PAB	Appendix 3B		10/09/12	90.31KB	Share
PAB	Patrys Completes Capital Raising		10/09/12	245.66KB	Share
PAB	Patrys 2012 Annual Report		23/08/12	4.19MB	Share
PAB	Appendix 4E and 2012 Annual Report	PRICE SENSITIVE	23/08/12	4.21MB	Share
PAB	Becoming a substantial holder		22/08/12	336.49KB	Share
PAB	Change in substantial holding		22/08/12	118.98KB	Share
PAB	Change of Director's Interest Notice		21/08/12	96.44KB	Share
PAB	Change of Director's Interest Notice		21/08/12	98.23KB	Share
PAB	Section 708A - Cleansing Statement		21/08/12	243.9KB	Share
PAB	Appendix 3B		21/08/12	95.7KB	Share
PAB	Results of EGM		15/08/12	367.31KB	Share
PAB	Appendix 4C - Quarterly Cash Flow - June 2012	PRICE SENSITIVE	26/07/12	91.88KB	Share
PAB	Share Purchase Plan documentation		19/07/12	151.23KB	Share
PAB	Cleansing Statement		19/07/12	74.21KB	Share
PAB	Capital Raising - Notice of EGM 15 August 2012 & Proxy		16/07/12	410.96KB	Share
PAB	Ceasing to be a substantial holder		12/07/12	44.71KB	Share
PAB	Change in substantial holding		09/07/12	65.3KB	Share
PAB	Cleansing Statement		29/06/12	382.04KB	Share
PAB	Appendix 3B		29/06/12	209.22KB	Share
PAB	SPP Record Date		28/06/12	234.4KB	Share
PAB	Becoming a substantial holder		25/06/12	73.89KB	Share
PAB	Patrys Capital Raising	PRICE SENSITIVE	22/06/12	295.78KB	Share
PAB	Trading halt	PRICE SENSITIVE	20/06/12	208.62KB	Share
PAB	Expiry of Options		29/05/12	131.99KB	Share
PAB	Patrys Granted Key Patent for Lead Product PAT-SM6	PRICE SENSITIVE	24/05/12	360.4KB	Share
PAB	Appendix 4C - Quarterly Cash Flow - March 2012	PRICE SENSITIVE	13/04/12	110.03KB	Share
PAB	Patrys Non-Deal U.S. Roadshow Presentation		12/04/12	2.28MB	Share
PAB	Patrys Announces Successful Phase I PAT-SM6 Clinical Trial	PRICE SENSITIVE	20/03/12	321.45KB	Share
PAB	Change of Director's Interest Notice		09/03/12	130.39KB	Share
PAB	Release of Shares from Voluntary Escrow		21/02/12	56.81KB	Share
PAB	Ceasing to be a substantial holder		20/02/12	45.37KB	Share
PAB	Half Yearly Report and Accounts - December 2011	PRICE SENSITIVE	17/02/12	571.02KB	Share
PAB	NAOS Increases Shareholding to 7.6%	PRICE SENSITIVE	17/02/12	261.36KB	Share
PAB	Patrys Provides Business Development Update		17/02/12	372.32KB	Share
PAB	Change in substantial holding		16/02/12	61.81KB	Share
PAB	Becoming a substantial holder		15/02/12	71.1KB	Share
PAB	Ceasing to be a substantial holder		13/02/12	46.4KB	Share
PAB	Change in substantial holding		10/02/12	60.49KB	Share
PAB	Becoming a substantial holder		09/02/12	75.28KB	Share
PAB	Patrys Completes PAT-SM6 Clinical Trial for Melanoma	PRICE SENSITIVE	09/02/12	331.51KB	Share
PAB	Ceasing to be a substantial holder		31/01/12	45.44KB	Share
PAB	Ceasing to be a substantial holder		23/01/12	395.91KB	Share
PAB	Change in substantial holding		20/01/12	59.31KB	Share
PAB	Appendix 4C - Quarterly Cash Flow - December 2011	PRICE SENSITIVE	19/01/12	110.05KB	Share
PAB	Copy of ASIC Form 484 - Loan Share Plan Buy Back		19/01/12	76.71KB	Share
PAB	Daily share buy-back notice - Appendix 3E		19/01/12	132.06KB	Share
PAB	Final share buy-back notice - Appendix 3F		19/01/12	124.49KB	Share
PAB	Change of Director's Interest Notice		19/01/12	114.98KB	Share
PAB	Change of Director's Interest Notice		19/01/12	114.28KB	Share
PAB	Change of Director's Interest Notice		19/01/12	115.27KB	Share
PAB	Appendix 3B		19/01/12	136.65KB	Share
PAB	Section 708A - Cleansing Statement		19/01/12	257.77KB	Share
PAB	Results of Meeting - EGM 11 January 2012		11/01/12	389.6KB	Share
PAB	Appendix 3C - Loan Share Plan Buy Back		03/01/12	150.24KB	Share
PAB	Initial Director's Interest Notice		20/12/11	96.03KB	Share
PAB	Planning for Patrys' Multiple Myeloma Trial Underway	PRICE SENSITIVE	19/12/11	355.75KB	Share
PAB	Suzy Jones Joins the Patrys Board		15/12/11	282.93KB	Share
PAB	Notice of Extraordinary General Meeting/Proxy Form 11/1/12		09/12/11	611.03KB	Share
PAB	Section 708A - Cleansing Statement		08/12/11	257.74KB	Share
PAB	Appendix 3B		08/12/11	139.06KB	Share
PAB	Patrys Announces Oversubscribed Capital Raising of AU$3.4 M	PRICE SENSITIVE	02/12/11	353.23KB	Share
PAB	Reinstatement to Official Quotation	PRICE SENSITIVE	02/12/11	41.22KB	Share
PAB	Request for Suspension from Official Quotation		01/12/11	76.53KB	Share
PAB	Suspension from Official Quotation	PRICE SENSITIVE	01/12/11	45.58KB	Share
PAB	Results of Meeting - 2011 AGM		30/11/11	367.19KB	Share
PAB	CEO's Presentation to AGM 2011		30/11/11	825.64KB	Share
PAB	Trading Halt Request		29/11/11	75.94KB	Share
PAB	Trading Halt	PRICE SENSITIVE	29/11/11	46.66KB	Share
PAB	Appendix 4C - Quarterly Cash Flow - September 2011	PRICE SENSITIVE	31/10/11	92.44KB	Share
PAB	Notice of Annual General Meeting/Proxy Form		28/10/11	462.25KB	Share
PAB	Initial Director's Interest Notice		19/10/11	96.12KB	Share
PAB	Patrys' CEO Dr. Marie Roskrow Joins the Board	PRICE SENSITIVE	19/10/11	291.42KB	Share
PAB	Patrys Update on Large Scale Manufacturing of PAT-SM6	PRICE SENSITIVE	17/10/11	385.85KB	Share
PAB	Patrys Investor Presentation - October 2011		10/10/11	1.17MB	Share
PAB	Significant Survival Benefit for PAT-SC1 Treated Patients	PRICE SENSITIVE	27/09/11	423.1KB	Share
PAB	Annual Report to shareholders		26/09/11	1.53MB	Share
PAB	PAT-SM6 Shows Promise in Multiple Myeloma	PRICE SENSITIVE	26/09/11	328.77KB	Share
PAB	PAT-SM6 Shows Promise in Additional Cancer Indications	PRICE SENSITIVE	20/09/11	334.45KB	Share
PAB	Patrys Adds Second Clinical Centre for PAT-SM6 Trial	PRICE SENSITIVE	19/09/11	331.75KB	Share
PAB	Securities Trading Policy		30/08/11	49.34KB	Share
PAB	Appendix 4E - Preliminary Final Report - June 2011	PRICE SENSITIVE	26/08/11	570.74KB	Share
PAB	Patrys' PAT-SM6 Antibody Detected in Patient Tumours	PRICE SENSITIVE	22/08/11	328.58KB	Share
PAB	Patrys Product Shows Promise in Multiple Myeloma	PRICE SENSITIVE	17/08/11	359.47KB	Share
PAB	Appendix 4C - Quarterly Cash Flow - June 2011	PRICE SENSITIVE	29/07/11	112.79KB	Share
PAB	Patrys Progresses PAT-SM6 Melanoma Trial	PRICE SENSITIVE	25/07/11	325.48KB	Share
PAB	Change in substantial holding		06/07/11	57.17KB	Share
PAB	Final Director's Interest Notice		01/07/11	97.42KB	Share
PAB	Patrys' PAT-SM6 Inhibits Metastases in Melanoma Cancer Model	PRICE SENSITIVE	27/06/11	371.68KB	Share
PAB	Patrys CEO Interviews	PRICE SENSITIVE	22/06/11	706.83KB	Share
PAB	Collaborations Support PAT-SM6 Clinical Program	PRICE SENSITIVE	20/06/11	377.61KB	Share

PABResults of Meeting - 2012 AGM
31/10/12		365.59KB	Share
PABCEO Presentation to AGM 2012
31/10/12		1.35MB	Share
PABPatrys Research Recognised by Leading Oncology Society
25/10/12		277.81KB	Share
PABAppendix 4C - Quarterly Cash Flow - September 2012
12/10/12	PRICE SENSITIVE	66.85KB	Share
PABNotice of Annual General Meeting/Proxy Form
28/09/12		615.07KB	Share
PABNew Data Published on Patrys' PAT-SM6 Lead Product
21/09/12	PRICE SENSITIVE	350.5KB	Share
PABPatrys Receives Approval for Multiple Myeloma Trial
20/09/12	PRICE SENSITIVE	350.29KB	Share
PABChange of Director's Interest Notice
10/09/12		96.06KB	Share
PABChange of Director's Interest Notice
10/09/12		95.98KB	Share
PABChange of Director's Interest Notice
10/09/12		97.41KB	Share
PABAppendix 3B
10/09/12		90.31KB	Share
PABPatrys Completes Capital Raising
10/09/12		245.66KB	Share
PABPatrys 2012 Annual Report
23/08/12		4.19MB	Share
PABAppendix 4E and 2012 Annual Report
23/08/12	PRICE SENSITIVE	4.21MB	Share
PABBecoming a substantial holder
22/08/12		336.49KB	Share
PABChange in substantial holding
22/08/12		118.98KB	Share
PABChange of Director's Interest Notice
21/08/12		96.44KB	Share
PABChange of Director's Interest Notice
21/08/12		98.23KB	Share
PABSection 708A - Cleansing Statement
21/08/12		243.9KB	Share
PABAppendix 3B
21/08/12		95.7KB	Share
PABResults of EGM
15/08/12		367.31KB	Share
PABAppendix 4C - Quarterly Cash Flow - June 2012
26/07/12	PRICE SENSITIVE	91.88KB	Share
PABShare Purchase Plan documentation
19/07/12		151.23KB	Share
PABCleansing Statement
19/07/12		74.21KB	Share
PABCapital Raising - Notice of EGM 15 August 2012 & Proxy
16/07/12		410.96KB	Share
PABCeasing to be a substantial holder
12/07/12		44.71KB	Share
PABChange in substantial holding
09/07/12		65.3KB	Share
PABCleansing Statement
29/06/12		382.04KB	Share
PABAppendix 3B
29/06/12		209.22KB	Share
PABSPP Record Date
28/06/12		234.4KB	Share
PABBecoming a substantial holder
25/06/12		73.89KB	Share
PABPatrys Capital Raising
22/06/12	PRICE SENSITIVE	295.78KB	Share
PABTrading halt
20/06/12	PRICE SENSITIVE	208.62KB	Share
PABExpiry of Options
29/05/12		131.99KB	Share
PABPatrys Granted Key Patent for Lead Product PAT-SM6
24/05/12	PRICE SENSITIVE	360.4KB	Share
PABAppendix 4C - Quarterly Cash Flow - March 2012
13/04/12	PRICE SENSITIVE	110.03KB	Share
PABPatrys Non-Deal U.S. Roadshow Presentation
12/04/12		2.28MB	Share
PABPatrys Announces Successful Phase I PAT-SM6 Clinical Trial
20/03/12	PRICE SENSITIVE	321.45KB	Share
PABChange of Director's Interest Notice
09/03/12		130.39KB	Share
PABRelease of Shares from Voluntary Escrow
21/02/12		56.81KB	Share
PABCeasing to be a substantial holder
20/02/12		45.37KB	Share
PABHalf Yearly Report and Accounts - December 2011
17/02/12	PRICE SENSITIVE	571.02KB	Share
PABNAOS Increases Shareholding to 7.6%
17/02/12	PRICE SENSITIVE	261.36KB	Share
PABPatrys Provides Business Development Update
17/02/12		372.32KB	Share
PABChange in substantial holding
16/02/12		61.81KB	Share
PABBecoming a substantial holder
15/02/12		71.1KB	Share
PABCeasing to be a substantial holder
13/02/12		46.4KB	Share
PABChange in substantial holding
10/02/12		60.49KB	Share
PABBecoming a substantial holder
09/02/12		75.28KB	Share
PABPatrys Completes PAT-SM6 Clinical Trial for Melanoma
09/02/12	PRICE SENSITIVE	331.51KB	Share
PABCeasing to be a substantial holder
31/01/12		45.44KB	Share
PABCeasing to be a substantial holder
23/01/12		395.91KB	Share
PABChange in substantial holding
20/01/12		59.31KB	Share
PABAppendix 4C - Quarterly Cash Flow - December 2011
19/01/12	PRICE SENSITIVE	110.05KB	Share
PABCopy of ASIC Form 484 - Loan Share Plan Buy Back
19/01/12		76.71KB	Share
PABDaily share buy-back notice - Appendix 3E
19/01/12		132.06KB	Share
PABFinal share buy-back notice - Appendix 3F
19/01/12		124.49KB	Share
PABChange of Director's Interest Notice
19/01/12		114.98KB	Share
PABChange of Director's Interest Notice
19/01/12		114.28KB	Share
PABChange of Director's Interest Notice
19/01/12		115.27KB	Share
PABAppendix 3B
19/01/12		136.65KB	Share
PABSection 708A - Cleansing Statement
19/01/12		257.77KB	Share
PABResults of Meeting - EGM 11 January 2012
11/01/12		389.6KB	Share
PABAppendix 3C - Loan Share Plan Buy Back
03/01/12		150.24KB	Share
PABInitial Director's Interest Notice
20/12/11		96.03KB	Share
PABPlanning for Patrys' Multiple Myeloma Trial Underway
19/12/11	PRICE SENSITIVE	355.75KB	Share
PABSuzy Jones Joins the Patrys Board
15/12/11		282.93KB	Share
PABNotice of Extraordinary General Meeting/Proxy Form 11/1/12
09/12/11		611.03KB	Share
PABSection 708A - Cleansing Statement
08/12/11		257.74KB	Share
PABAppendix 3B
08/12/11		139.06KB	Share
PABPatrys Announces Oversubscribed Capital Raising of AU$3.4 M
02/12/11	PRICE SENSITIVE	353.23KB	Share
PABReinstatement to Official Quotation
02/12/11	PRICE SENSITIVE	41.22KB	Share
PABRequest for Suspension from Official Quotation
01/12/11		76.53KB	Share
PABSuspension from Official Quotation
01/12/11	PRICE SENSITIVE	45.58KB	Share
PABResults of Meeting - 2011 AGM
30/11/11		367.19KB	Share
PABCEO's Presentation to AGM 2011
30/11/11		825.64KB	Share
PABTrading Halt Request
29/11/11		75.94KB	Share
PABTrading Halt
29/11/11	PRICE SENSITIVE	46.66KB	Share
PABAppendix 4C - Quarterly Cash Flow - September 2011
31/10/11	PRICE SENSITIVE	92.44KB	Share
PABNotice of Annual General Meeting/Proxy Form
28/10/11		462.25KB	Share
PABInitial Director's Interest Notice
19/10/11		96.12KB	Share
PABPatrys' CEO Dr. Marie Roskrow Joins the Board
19/10/11	PRICE SENSITIVE	291.42KB	Share
PABPatrys Update on Large Scale Manufacturing of PAT-SM6
17/10/11	PRICE SENSITIVE	385.85KB	Share
PABPatrys Investor Presentation - October 2011
10/10/11		1.17MB	Share
PABSignificant Survival Benefit for PAT-SC1 Treated Patients
27/09/11	PRICE SENSITIVE	423.1KB	Share
PABAnnual Report to shareholders
26/09/11		1.53MB	Share
PABPAT-SM6 Shows Promise in Multiple Myeloma
26/09/11	PRICE SENSITIVE	328.77KB	Share
PABPAT-SM6 Shows Promise in Additional Cancer Indications
20/09/11	PRICE SENSITIVE	334.45KB	Share
PABPatrys Adds Second Clinical Centre for PAT-SM6 Trial
19/09/11	PRICE SENSITIVE	331.75KB	Share
PABSecurities Trading Policy
30/08/11		49.34KB	Share
PABAppendix 4E - Preliminary Final Report - June 2011
26/08/11	PRICE SENSITIVE	570.74KB	Share
PABPatrys' PAT-SM6 Antibody Detected in Patient Tumours
22/08/11	PRICE SENSITIVE	328.58KB	Share
PABPatrys Product Shows Promise in Multiple Myeloma
17/08/11	PRICE SENSITIVE	359.47KB	Share
PABAppendix 4C - Quarterly Cash Flow - June 2011
29/07/11	PRICE SENSITIVE	112.79KB	Share
PABPatrys Progresses PAT-SM6 Melanoma Trial
25/07/11	PRICE SENSITIVE	325.48KB	Share
PABChange in substantial holding
06/07/11		57.17KB	Share
PABFinal Director's Interest Notice
01/07/11		97.42KB	Share
PABPatrys' PAT-SM6 Inhibits Metastases in Melanoma Cancer Model
27/06/11	PRICE SENSITIVE	371.68KB	Share
PABPatrys CEO Interviews
22/06/11	PRICE SENSITIVE	706.83KB	Share
PABCollaborations Support PAT-SM6 Clinical Program
20/06/11	PRICE SENSITIVE	377.61KB	Share

REFRESH

First 3 4 5 6 7

(20min delay)
Last 0.9¢		Change 0.000(0.00%)		Mkt cap ! $18.51M

Open	High	Low	Value	Volume
0.9¢	0.9¢	0.9¢	$18.68K	2.075M

Buyers (Bids)

No.	Vol.	Price($)
11	2642383	0.8¢

Sellers (Offers)

Price($)	Vol.	No.
0.9¢	856022	2

View Market Depth

No.	Vol.	Price($)
11	2642383	0.008
17	4746715	0.007
11	2787680	0.006
8	3144992	0.005
5	4324000	0.004

Price($)	Vol.	No.
0.009	856022	2
0.010	1830082	5
0.011	1380000	4
0.012	372407	3
0.013	990000	2

Last trade - 16.10pm 26/04/2024 (20 minute delay)


Last 0.9¢		Change 0.000 ( 0.00 %)
Open	High	Low	Volume
0.9¢	0.9¢	0.9¢	97616
Last updated 11.58am 26/04/2024 ?

PAB (ASX) Chart

PATRYS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available